Revista de la Sociedad Argentina de Diabetes
LABORATORIO DE REPRODUCCIÓN Y METABOLISMO CEFYBO-CONICET. FACULTAD DE MEDICINA, UBA
Resumen
Palabras clave
Texto completo:
PDFReferencias
McCance DR. Diabetes in pregnancy. Best Pract Res Clin Obstet Gynaecol 2015; 29:685-99.
Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC, et al. The International Federation of Gynecology and Obstetrics (FIGO). Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management and care. Int J Gynaecol Obstet 2015; 131 Suppl 3:S173.
Lappas M, Hiden U, Desoye G, Froehlich J, Hauguel-de Mouzon S, Jawerbaum A. The role of oxidative stress in the pathophysiology of gestational diabetes mellitus. Antioxid Redox Signal 2011; 15:3061-100.
Mitanchez D, Yzydorczyk C, Simeoni U. What neonatal complications should the pediatrician be aware of in case of maternal gestational diabetes? World J Diabetes 2015; 6:734-43.
Jawerbaum A, White V. Animal models in diabetes and pregnancy. Endocr Rev 2010; 31:680-701.
Jawerbaum A, González E. Diabetic pregnancies: the challenge of developing in a pro-inflammatory environment. Curr Med Chem 2006; 13:2127-38.
Capobianco E, Pelesson M, Careaga V, Fornes D, Canosa I, Higa R, et al. Intrauterine programming of lipid metabolic alterations in the heart of the offspring of diabetic rats is prevented by maternal diets enriched in olive oil. Mol Nutr Food Res 2015; 59:1997-2007.
Capobianco E, White V, Sosa M, Marco ID, Basualdo MN, Faingold MC, et al. Regulation of matrix metalloproteinases 2 and 9 activities by peroxynitrites in term placentas from type 2 diabetic patients. Reprod Sci 2012; 19:814-22.
Wahli W, Michalik L. PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrinol Metab 2012; 23:351-63.
Jawerbaum A, Capobianco E. Review: effects of PPAR activation in the placenta and the fetus: implications in maternal diabetes. Placenta 2011; 32 Suppl 2:S212-7.
Higa R, González E, Pustovrh MC, White V, Capobianco E, Martínez N, et al. PPARdelta and its activator PGI2 are reduced in diabetic embryopathy: involvement of PPARdelta activation in lipid metabolic and signalling pathways in rat embryo early organogenesis. Mol Hum Reprod 2007; 13:103-10.
Pustovrh MC, Capobianco E, Martínez N, Higa R, White V, Jawerbaum A. MMP/TIMP balance is modulated in vitro by 15dPGJ(2) in fetuses and placentas from diabetic rats. Eur J Clin Invest 2009; 39:1082-90.
Martínez N, Capobianco E, White V, Pustovrh MC, Higa R, Jawerbaum A. Peroxisome proliferator-activated receptor alpha activation regulates lipid metabolism in the feto-placental unit from diabetic rats. Reproduction 2008; 136:95-103.
Capobianco E, Martínez N, Fornes D, Higa R, Di Marco I, Basualdo MN, et al. PPAR activation as a regulator of lipid metabolism, nitric oxide production and lipid peroxidation in the placenta from type 2 diabetic patients. Mol Cell Endocrinol 2013; 377:7-15.
Kurtz M, Capobianco E, Martínez N, Roberti SL, Arany E, Jawerbaum A. PPAR ligands improve impaired metabolic pathways in fetal hearts of diabetic rats. J Mol Endocrinol 2014; 53:237-46.
Capobianco E, Fornes D, Linenberg I, Powell TL, Jansson T, Jawerbaum A. A novel rat model of gestational diabetes induced by intrauterine programming is associated with alterations in placental signaling and fetal overgrowth. Mol Cell Endocrinol 2016; 422:221-32.
Mazzucco MB, Fornes D, Capobianco E, Higa R, Jawerbaum A, White V. Maternal saturated-fat-rich diet promotes leptin resistance in fetal liver lipid catabolism and programs lipid homeostasis impairments in the liver of rat offspring. J Nutr Biochem 2016; 27:61-9.
Jawerbaum A, White V. Review on intrauterine programming: consequences in rodent models of mild diabetes and mild fat overfeeding are not mild. Placenta 2017; 52:21-32.
DOI: http://dx.doi.org/10.47196/diab.v51i1.48
Copyright (c) 2018 Revista de la Sociedad Argentina de Diabetes (SAD) - Versión de prueba
